Muscuric agonists

Definition: Muscarinic agonists are compounds that activate muscarinic receptors in the body, which are involved in the parasympathetic nervous system response (rest and digest).
Clinical Relevance: Unlike nicotinic agonists, muscarinic agonists have various therapeutic uses primarily due to their effects on secretory and involuntary functions (SLUD).

Nicotinic Agonists: Nicotine primarily discussed in the context of drug abuse, with no significant therapeutic uses noted for peripheral nicotinic antagonists.
Muscarinic Agonists: Have clear clinical uses focused on enhancing SLUD activities, which include salivation, lacrimation, urination, and digestion.

Receptor Locations:
- Found on postganglionic parasympathetic neurons and certain special locations like sweat glands and endothelial cells of blood vessels.
Effects:
- SLUD Symptoms: Increases in salivation, lacrimation, urination, and digestion.
- Cardiovascular: Decreased peripheral resistance and heart rate (bradycardia).
- Respiratory: Can cause bronchoconstriction and increase secretions.
- Ocular Effects: Facilitate constriction of the pupil (miosis) and improve fluid drainage in glaucoma treatment.
- Urinary Effects: Constricts bladder & relaxes sphincter improving urination.

Acetylcholine: Activates both muscarinic and nicotinic receptors; rapidly broken down by acetylcholinesterase.
Cholinesters:
- Methacholine: Used in diagnosing asthma.
- Carbachol: Reduces intraocular pressure; useful in glaucoma.
- Bethanechol: Used for urinary retention and bowel issues.
Alkaloids:
- Pilocarpine: Not a substrate for acetylcholinesterase; crosses the blood-brain barrier, used for glaucoma and xerostomia (dry mouth) due to Sjogren's syndrome.

Positive Charge: Most synthetic muscarinic agonists are positively charged, which limits their ability to cross the blood-brain barrier. Pilocarpine is distinct as it is neutral and can cross the barrier and exert effects on the CNS.
Ester vs. Alkaloid Differences: Cholinergic esters are rapidly hydrolyzed and have limited absorption compared to alkaloids like pilocarpine, which are well-absorbed and have extended action durations.

Post-operative Urinary Retention: Assist in urination by contracting bladder muscles and relaxing sphincters.
Xerostomia Treatment: Pilocarpine and synthetic analogs like Savimeline are approved for conditions leading to dry mouth, such as Sjogren's syndrome.
Glaucoma Management: Muscarinic agonists improve aqueous humor drainage and decrease intraocular pressure.

Excessive secretions: Diarrhea, muscle cramps, and gastrointestinal distress. May necessitate the use of muscarinic antagonists to mitigate symptoms. Adverse effects include cold sweats and increased secretions if the drug enters systemic circulation.

Myotic Effect: Producing miosis to assist patients with accommodation (focusing) problems.
Risk of Asthmatic Reactions: Low doses may induce bronchoconstriction in susceptible individuals.
Antimuscarinic Drug Intoxication: Muscarinic agonists can counteract effects of drugs like atropine that inhibit muscarinic activity.

Muscarinic agonists play a crucial role in enhancing parasympathetic activities, particularly in therapeutic scenarios involving urinary retention, xerostomia, and glaucoma management, while also presenting specific adverse effects that may require careful monitoring.